Seattle Genetics (SGEN) Tops Q3 EPS by 6c

October 27, 2016 4:13 PM EDT

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Seattle Genetics (NASDAQ: SGEN) reported Q3 EPS of ($0.23), $0.06 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $106.3 million versus the consensus estimate of $101.74 million.

For earnings history and earnings-related data on Seattle Genetics (SGEN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment